Rangaswamy Iyer Board Membership
About Rangaswamy Iyer
- Mr. Rangaswamy Iyer was appointed as an Independent Director of Atul Ltd effective May 01, 2023, for a term of five consecutive years, concluding on April 30, 2028.
- He brings extensive knowledge and expertise relevant to the company's operations, bolstered by nearly four decades of experience in the healthcare industry, including roles in Animal Health, Biologicals, Consumer Healthcare, and Pharmaceuticals, as well as in mergers and acquisitions.
- Prior to this role, Mr. Iyer served as the Chief Financial Officer and Finance Director of Cyanamid India Ltd and later became the Managing Director of Wyeth Ltd. He holds postgraduate degrees in Commerce and Financial Management from the University of Mumbai and is also a senior advisor to Lincoln International, USA, providing consultancy to various multinational and Indian pharma companies, private equity firms, and investment bankers in business strategy and development.
- Additionally, he serves on the Audit Committee and the Nomination and Remuneration Committee of Atul Bioscience Ltd.
List of Companies Associated with Rangaswamy Iyer
| Company Name |  Position Held |
|---|---|
| Atul Ltd | Independent Director |
Historical Share Prices
Rangaswamy Iyer Sector Specific Experience
About Rangaswamy Iyer's Work Experience
- Rangaswamy Iyer is currently a Independent Director in Atul Ltd (as of Mar 2024).
- Rangaswamy Iyer is serving the company - Atul Ltd at this position since 2024 for the last 3+ years.
- Prior to becoming Independent Director, Rangaswamy Iyer was Independent Director of Sanofi India Ltd for 2 years from 2016 to 2017.
- Before becoming Independent Director, Rangaswamy Iyer was Addtnl Independent Director of Aurobindo Pharma Ltd for 1 year in 2016.
- Prior to becoming Addtnl Independent Director, Rangaswamy Iyer was Director of Sanofi India Ltd for 2 years from 2014 to 2015.
FAQ's related Rangaswamy Iyer
Who is Rangaswamy Iyer
Mr. Rangaswamy Iyer was appointed as an Independent Director of Atul Ltd effective May 01, 2023, for a term of five consecutive years, concluding on April 30, 2028. He brings extensive knowledge and expertise relevant to the company's operations, bolstered by nearly four decades of experience in the healthcare industry, including roles in Animal Health, Biologicals, Consumer Healthcare, and Pharmaceuticals, as well as in mergers and acquisitions. Prior to this role, Mr. Iyer served as the Chief Financial Officer and Finance Director of Cyanamid India Ltd and later became the Managing Director of Wyeth Ltd. He holds postgraduate degrees in Commerce and Financial Management from the University of Mumbai and is also a senior advisor to Lincoln International, USA, providing consultancy to various multinational and Indian pharma companies, private equity firms, and investment bankers in business strategy and development. Additionally, he serves on the Audit Committee and the Nomination and Remuneration Committee of Atul Bioscience Ltd.
Which companies does Rangaswamy Iyer serve as a board member for?
Rangaswamy Iyer serves as a board member for: Atul Ltd,Sanofi India Ltd,Aurobindo Pharma Ltd
What positions has Rangaswamy Iyer held in his/her career?
Throughout their career, Rangaswamy Iyer has held key positions such as Independent Director,Addtnl Independent Director,Director, contributing to the growth and success of each company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
